Dexcom Inc logo

DXCM

Dexcom Inc

$87.77

Earnings Summary

Revenue
$696.2Mn
Net Profits
$50.9Mn
Net Profit Margins
7.31%
PE Ratio
208.91

Highlights

Revenue:

Dexcom Inc’s revenue jumped 16.99% since last year same period to $696.2Mn in the Q2 2022. On a quarterly growth basis, Dexcom Inc has generated 10.72% jump in its revenue since last 3-months.

Net Profits:

Dexcom Inc’s net profit fell -19.08% since last year same period to $50.9Mn in the Q2 2022. On a quarterly growth basis, Dexcom Inc has generated -47.69% fall in its net profits since last 3-months.

Net Profit Margins:

Dexcom Inc’s net profit margin fell -30.83% since last year same period to 7.31% in the Q2 2022. On a quarterly growth basis, Dexcom Inc has generated -52.75% fall in its net profit margins since last 3-months.

PE Ratio:

Dexcom Inc’s price-to-earnings ratio after this Q2 2022 earnings stands at 208.91.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Dexcom Inc post its latest quarter earnings

EPS Estimate Current Quarter
0.25
EPS Estimate Current Year
0.25

Highlights

EPS Estimate Current Quarter:

Dexcom Inc’s earning per share (EPS) estimates for the current quarter stand at 0.25 - a 31.58% jump from last quarter’s estimates.

EPS Estimate Current Year:

Dexcom Inc’s earning per share (EPS) estimates for the current year stand at 0.25.

Key Ratios

Key ratios of the Dexcom Inc post its Q2 2022 earnings

Earning Per Share (EPS)
0.17
Return on Assets (ROA)
0.03
Return on Equity (ROE)
0.08
Dividend Per Share (DPS)
0

Highlights

Earning Per Share (EPS):

Dexcom Inc’s earning per share (EPS) fell -10.53% since last year same period to 0.17 in the Q2 2022. This indicates that the Dexcom Inc has generated -10.53% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Dexcom Inc’s return on assets (ROA) stands at 0.03.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Dexcom Inc’s return on equity (ROE) stands at 0.08.

Dividend Per Share (DPS):

Dexcom Inc declared 0 dividend per share during the earnings announcement for Q2 2022.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-07-28
0.19
0.17
-10.53%
2022-04-28
0.13
0.08
-38.46%

Company Information

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.

Organisation
Dexcom Inc
Headquarters
San Diego, California, US
Employees
5.5K
Industry
Health Technology
CEO
Kevin Sayer